These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10028864)

  • 1. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
    Aydinli N; Calişkan M; Calay M; Ozmen M
    Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton NMR spectroscopy of Canavan's disease.
    Barker PB; Bryan RN; Kumar AJ; Naidu S
    Neuropediatrics; 1992 Oct; 23(5):263-7. PubMed ID: 1454147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
    Wittsack HJ; Kugel H; Roth B; Heindel W
    J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.
    Assadi M; Janson C; Wang DJ; Goldfarb O; Suri N; Bilaniuk L; Leone P
    Eur J Paediatr Neurol; 2010 Jul; 14(4):354-9. PubMed ID: 20034825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canavan disease: a review of recent developments.
    Gordon N
    Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Hanefeld F; Holzbach U; Kruse B; Wilichowski E; Christen HJ; Frahm J
    Neuropediatrics; 1993 Oct; 24(5):244-8. PubMed ID: 8309512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.
    Marks HG; Caro PA; Wang ZY; Detre JA; Bogdan AR; Gusnard DA; Zimmerman RA
    Ann Neurol; 1991 Jul; 30(1):106-10. PubMed ID: 1929222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
    Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
    Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy.
    Kok RD; van den Bergh AJ; Heerschap A; Nijland R; van den Berg PP
    Am J Obstet Gynecol; 2001 Nov; 185(5):1011-5. PubMed ID: 11717623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
    i Dali C; Hanson LG; Barton NW; Fogh J; Nair N; Lund AM
    Neurology; 2010 Nov; 75(21):1896-903. PubMed ID: 21098404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Zawada B; Otapowicz D
    J Child Neurol; 2009 Jan; 24(1):73-9. PubMed ID: 18936194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.